Oxford-AstraZeneca coronary vaccine re-trial in India, DCGI approves serum institute

The Comptroller General of Indian Medicine (DCGI) has allowed the Serum Institute of India (SII) to re-launch a clinical trial of the coronavirus vaccine in Oxfor